These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26075249)

  • 1. Modern evaluation of liquisolid systems with varying amounts of liquid phase prepared using two different methods.
    Vraníková B; Gajdziok J; Vetchý D
    Biomed Res Int; 2015; 2015():608435. PubMed ID: 26075249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of superdisintegrants on the properties and dissolution profiles of liquisolid tablets containing rosuvastatin.
    Vraníková B; Gajdziok J; Doležel P
    Pharm Dev Technol; 2017 Mar; 22(2):138-147. PubMed ID: 26401959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EVALUATION OF SORPTIVE PROPERTIES OF VARIOUS CARRIERS AND COATING MATERIALS FOR LIQUISOLID SYSTEMS.
    Vraníková B; Gajdziok J
    Acta Pol Pharm; 2015; 72(3):539-49. PubMed ID: 26642662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
    Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
    Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-microemulsifying tablets prepared by direct compression for improved resveratrol delivery.
    Bolko Seljak K; Ilić IG; Gašperlin M; Zvonar Pobirk A
    Int J Pharm; 2018 Sep; 548(1):263-275. PubMed ID: 29969713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of flowable liquid retention potential of aluminometasilicate carrier for liquisolid systems preparation.
    Vraníková B; Gajdziok J; Vetchý D
    Pharm Dev Technol; 2015 Nov; 20(7):839-844. PubMed ID: 24927105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-based formulations solidified via adsorption onto the mesoporous carrier Neusilin® US2: effect of drug type and formulation composition on in vitro pharmaceutical performance.
    Williams HD; Van Speybroeck M; Augustijns P; Porter CJ
    J Pharm Sci; 2014 Jun; 103(6):1734-46. PubMed ID: 24740767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
    Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
    Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of the coating material type and amount in the preparation of liquisolid systems based on magnesium aluminometasilicate carrier.
    Vraníková B; Svačinová P; Marushka J; Brokešová J; Holas O; Tebbens JD; Šklubalová Z
    Eur J Pharm Sci; 2021 Oct; 165():105952. PubMed ID: 34298140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spironolactone release from liquisolid formulations prepared with Capryol™ 90, Solutol® HS-15 and Kollicoat® SR 30 D as non-volatile liquid vehicles.
    Elkordy AA; Tan XN; Essa EA
    Eur J Pharm Biopharm; 2013 Feb; 83(2):203-23. PubMed ID: 22960707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin® US2.
    Shah A; Serajuddin AT
    Int J Pharm; 2015 Apr; 484(1-2):172-80. PubMed ID: 25724137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of a butyrylcholinesterase porous pellet for innovative detection of cholinesterase inhibitors.
    Zeman J; Vetchý D; Franc A; Pavloková S; Pitschmann V; Matějovský L
    Eur J Pharm Sci; 2017 Nov; 109():548-555. PubMed ID: 28917965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of fenofibrate liquisolid tablets using central composite design.
    Patel T; Patel LD; Suhagia BN; Soni T; Patel T
    Curr Drug Deliv; 2014; 11(1):11-23. PubMed ID: 24712439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of solid SEDDS, VI: Effect of precoating of Neusilin
    Gumaste SG; Freire BOS; Serajuddin ATM
    Eur J Pharm Sci; 2017 Dec; 110():124-133. PubMed ID: 28212981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of griseofulvin release from liquisolid compacts.
    Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
    Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preformulation studies on solid self-emulsifying systems in powder form containing magnesium aluminometasilicate as porous carrier.
    Krupa A; Szlęk J; Jany BR; Jachowicz R
    AAPS PharmSciTech; 2015 Jun; 16(3):623-35. PubMed ID: 25501870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs.
    Mura P; Valleri M; Cirri M; Mennini N
    Pharm Dev Technol; 2012; 17(3):277-84. PubMed ID: 21108583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous twin-screw granulation for enhancing the dissolution of poorly water soluble drug.
    Maniruzzaman M; Nair A; Renault M; Nandi U; Scoutaris N; Farnish R; Bradley MS; Snowden MJ; Douroumis D
    Int J Pharm; 2015 Dec; 496(1):52-62. PubMed ID: 26387621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.